| 2022 | | 258 (PB038) - SORT1 with oncogenic potential associated hypomethylation and promotes tumor progression in hepatocellular carcinoma | 김순선, 은정우, 정재연, 조효정, 한지은 |
| 2022 | | 295 (PB075) - Cancer-associated fibroblast-derived SPP1 is a potential target for overcoming sorafenib and lenvatinib resistance in hepatocellular carcinoma | 김순선, 은정우, 정재연, 조효정, 한지은 |
| 2022 | | 344 (PB124) - Statin in combination with cisplatin makes favorable tumor-immune microenvironment for immunotherapy of head and neck squamous cell carcinoma | 조효정 |
| 2023 | | Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma | 김봉완, 김순선, 은정우, 정재연, 조효정, 한지은 |
| 2021 | | Assessment of medical students’ clinical performance using high-fidelity simulation: comparison of peer and instructor assessment | 김미란, 김순선, 노충균, 송미령, 양민재, 유지혜, 이길호, 이미진, 이장훈, 정윤정, 조효정 |
| 2023 | | Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib | 김석휘, 김순선, 김영배, 은정우, 임수빈, 정재연, 조효정 |
| 2020 | | Circulating Exosomal MicroRNA-1307-5p as a Predictor for Metastasis in Patients with Hepatocellular Carcinoma | 김순선, 은정우, 정재연, 조효정 |
| 2023 | | Circulating small extracellular vesicle-derived splicing factor 3b subunit 4 as a non-invasive diagnostic biomarker of early hepatocellular carcinoma | 김순선, 은정우, 정재연, 조효정 |
| 2021 | | Combining hepatic surface nodularity and serum tests better predicts hepatic fibrosis stages in chronic liver disease | 김재근, 이제희, 조효정, 허지미 |
| 2023 | | Drug Induced Liver Injury Prediction with Injective Molecular Transformer | 김순선, 정재연, 조효정, 한지은 |
| 2021 | | Early detection of hepatocellular carcinoma via liquid biopsy: panel of small extracellular vesicle-derived long noncoding RNAs identified as markers | 김순선, 은정우, 정재연, 조효정 |
| 2022 | | Effect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatment | 김순선, 박범희, 정재연, 조효정, 한지은 |
| 2020 | | Exosomal microRNA-4661-5p-based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma | 김순선, 은정우, 정재연, 조효정 |
| 2023 | | Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes | 김순선, 정재연, 조효정 |
| 2021 | | Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: Radiologic and clinical factors predictive of survival | 권요한, 김재근, 김진우, 원제환, 조효정, 허지미 |
| 2021 | | HMBS is the most suitable reference gene for RT-qPCR in human HCC tissues and blood samples | 김순선, 은정우, 정재연, 조효정 |
| 2022 | | Hypomethylation-mediated upregulation of the WASF2 promoter region correlates with poor clinical outcomes in hepatocellular carcinoma | 강호철, 김순선, 은정우, 정재연, 조효정 |
| 2023 | | Impact of guideline adherence on the prognosis of Barcelona clinic liver cancer stage B hepatocellular carcinoma | 김순선, 노충균, 양민재, 이길호, 임선교, 정재연, 조효정, 한지은 |
| 2021 | | Independent risk factors for hepatocellular carcinoma recurrence after direct-acting antiviral therapy in patients with chronic hepatitis C | 김순선, 박범희, 정재연, 조효정 |
| 2021 | | Infiltrative hepatocellular carcinoma with multiple lung metastasis completely cured using nivolumab: a case report | 김순선, 정재연, 조효정, 한지은 |
| 2020 | | Liver stiffness in magnetic resonance elastography is prognostic for sorafenib-treated advanced hepatocellular carcinoma | 김보현, 김순선, 김재근, 이제희, 정재연, 조효정, 허지미 |
| 2020 | | Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment | 김보현, 김순선, 김재근, 은정우, 이제희, 정재연, 조효정, 허지미 |
| 2020 | | MLH1 single-nucleotide variant in circulating tumor DNA predicts overall survival of patients with hepatocellular carcinoma | 김순선, 우현구, 은정우, 정재연, 조효정, 최지혜 |
| 2022 | | Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma | 김순선, 은정우, 정재연, 조효정 |
| 2021 | | Overexpressed proteins in hcc cell-derived exosomes, CCT8, and cofilin-1 are potential biomarkers for patients with HCC | 김순선, 은정우, 정재연, 조효정 |
| 2022 | | Relationship between the dynamics of non-alcoholic fatty liver disease and incident diabetes mellitus | 김순선, 박범희, 정재연, 조효정, 한지은 |
| 2022 | | Risk Prediction Model Based on Magnetic Resonance Elastography-Assessed Liver Stiffness for Predicting Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma | 김봉완, 김순선, 김재근, 은정우, 이제희, 정재연, 조효정, 허지미 |
| 2021 | | Role of immune cells in patients with hepatitis b virus‐related hepatocellular carcinoma | 정재연, 조효정 |
| 2019 | | SAT-062-Edema index measured by bioelectrical impedance analysis predicts ascites or acute kidney injury after liver resection for hepatocellular carcinoma | 김봉완, 김순선, 왕희정, 은정우, 이길호, 정재연, 조효정 |
| 2020 | | Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma | 김순선, 은정우, 정재연, 조효정 |
| 2020 | | Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma | 김순선, 은정우, 정재연, 조효정 |
| 2021 | | Statin in combination with cisplatin makes favorable tumor-immune microenvironment for immunotherapy of head and neck squamous cell carcinoma | 조효정 |
| 2024 | | The Impact of Statins on the Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib or Lenvatinib | 김순선, 노충균, 박범희, 양민재, 은정우, 이길호, 임선교, 정재연, 조효정, 한지은 |
| 2020 | | Treatment and prognosis of hepatic epithelioid hemangioendothelioma based on SEER data analysis from 1973 to 2014 | 김순선, 노오규, 양민재, 임선교, 정재연, 조효정, 황재철 |
| 2023 | | Tumor Endothelial Cells-Associated Integrin Alpha-6 as a Promising Biomarker for Early Detection and Prognosis of Hepatocellular Carcinoma | 김순선, 은정우, 정재연, 조효정, 한지은 |
